APA (7th ed.) Citation

C, Z., R, S., A, X., A, L., J, M., PB, R., . . . V, M. (2024). iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer's disease. Molecular psychiatry, 29(11), 3644. https://doi.org/10.1038/s41380-024-02629-y

Chicago Style (17th ed.) Citation

C, Zivko, et al. "IPSC-derived Hindbrain Organoids to Evaluate Escitalopram Oxalate Treatment Responses Targeting Neuropsychiatric Symptoms in Alzheimer's Disease." Molecular Psychiatry 29, no. 11 (2024): 3644. https://doi.org/10.1038/s41380-024-02629-y.

MLA (9th ed.) Citation

C, Zivko, et al. "IPSC-derived Hindbrain Organoids to Evaluate Escitalopram Oxalate Treatment Responses Targeting Neuropsychiatric Symptoms in Alzheimer's Disease." Molecular Psychiatry, vol. 29, no. 11, 2024, p. 3644, https://doi.org/10.1038/s41380-024-02629-y.